August 2016 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for August 2016. This roundup includes the latest...
Comorbidity Factors Identified for Exacerbation-Prone Asthma
Blood eosinophils, BMI, bronchodilator responsiveness tied to exacerbation frequency
Salmeterol + Fluticasone Deemed Safe for Childhood Asthma
FDA to review findings, researcher says
ACA Is Helping More Americans Afford Prescriptions
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
Intranasal Steroids Underused in Chronic Rhinosinusitis
Rate of intranasal steroid spray utilization 20.1 per 100 patients; geographic variation in rate
Bronchiolitis Plus Gene Variant Raises Asthma Risk in Children
Higher risk seen in those with PAI-1 gene variant and serious respiratory infection at a young age
Higher Incidence of Edema With Bacteriuria in C1-INH-HAE
Findings in those with versus without bacteriuria in hereditary angioedema with C1-inhibitor deficiency
Cardiovascular Disease Risk Up in Late-Onset Asthma Patients
Doctors should be monitoring for high blood pressure, cholesterol closely in these patients
Steep Rise in U.S. Drug Prices Tied to Patent Monopolies
Letting Medicare and Medicaid negotiate pricing would likely help bring costs down, researchers say
ACA Has Increased Rx Drug Use, Cut Out-of-Pocket Spending
Larger decreases in out-of-pocket spending for those who gained coverage and had chronic conditions
